March 29, 2022
March 29, 2022 – The U.S. FDA has approved higher Ozempic® (semaglutide) dosing to improve glycemic control in adults who have type 2 diabetes. Ozempic, which previously
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
GlobalReach Health
March 29, 2022
March 29, 2022 – Both Pfizer and Moderna have received emergency use authorization (EUA) for a second
booster dose of their COVID-19 vaccines in certain populations. For both products
March 29, 2022
March 29, 2022 – The FDA has approved TlandoTM (testosterone undecanoate), made by Antares Pharma, for testosterone replacement therapy (TRT). Tlando is the first oral TRT
March 28, 2022
March 28, 2022 – UCB’s Fintepla® (fenfluramine) has obtained an expanded indication to treat seizures
associated with Dravet syndrome and Lennox-Gastaut syndrome in patients at
January 31, 2022
January, 2023 - The 2022 U.S. Generic and Biosimilar Medicines Savings Report, published by the Association for Accessible Medicines, found that the U.S.
January 21, 2022
January 21, 2022 – Selzentry (maraviroc) tablets – for HIV. Adverse reactions or quality problems
January 21, 2022
January 21, 2022 – The U.S. FDA has expanded approval and emergency use authorization (EUA) for Gilead's Veklury® (remdesivir) to treat COVID-19 in certain high-risk individuals
January 19, 2022
January 19, 2022 – Mylan Pharmaceuticals, a Viatris company, has recalled one batch of non-interchangeable Semglee® (insulin glargine injection), 100 units/mL (U-100) 3mL